Save information for later
Sign Up

Learn About Pseudomyxoma Peritonei

What is the definition of Pseudomyxoma Peritonei?
Pseudomyxoma peritonei (PMP) is a rare disease characterized by the presence of mucin in the abdominal (peritoneal) cavity. While the most common cause of PMP is appendix cancer, several types of tumors (including non-cancerous tumors) can cause PMP. Signs and symptoms may include an increase in abdominal size or bloating; inguinal hernia (in men); an ovarian mass that may be felt during a routine pelvic exam (in women); pain or discomfort in the abdomen; and/or appendicitis.
What are the alternative names for Pseudomyxoma Peritonei?
  • Pseudomyxoma peritonei
  • Adenomucinosis
  • Gelatinous ascites
  • PMP
  • Syndrome of pseudomyxoma peritonei
Who are the top Pseudomyxoma Peritonei Local Doctors?
Advanced in Pseudomyxoma Peritonei
Advanced in Pseudomyxoma Peritonei

City Of Hope Medical Group Of Arizona LLC

14200 W Celebrate Life Way, 
Goodyear, AZ 
 (2.7 mi)
Languages Spoken:
English
Offers Telehealth

Sagun Shrestha is an Oncologist in Goodyear, Arizona. Dr. Shrestha and is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, Breast Cancer, and Vertebroplasty.

Advanced in Pseudomyxoma Peritonei
Surgical Oncology | General Surgery
Advanced in Pseudomyxoma Peritonei
Surgical Oncology | General Surgery

City Of Hope Medical Group Of Arizona LLC

14200 W Celebrate Life Way, 
Goodyear, AZ 
 (2.7 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

David Luyimbazi is a Surgical Oncologist and a General Surgeon in Goodyear, Arizona. Dr. Luyimbazi and is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Luyimbazi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Pseudomyxoma Peritonei
Surgical Oncology | General Surgery
Experienced in Pseudomyxoma Peritonei
Surgical Oncology | General Surgery

City Of Hope Medical Group Of Arizona LLC

14200 W Celebrate Life Way, 
Goodyear, AZ 
 (2.7 mi)
Languages Spoken:
English
Offers Telehealth

Gagandeep Singh is a Surgical Oncologist and a General Surgeon in Goodyear, Arizona. Dr. Singh and is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Small Bowel Resection, and Pancreatectomy.

What are the latest Pseudomyxoma Peritonei Clinical Trials?
Fluorouracil-labeled Nascent RNA Technology for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

Summary: The main objective of this study is to combine HIPEC regimens with Flura-seq to detect the effects of different HIPEC regimens (cisplatin vs. cisplatin+ docetaxel) on the nascent transcriptome of PMP tumors, so as to quantitatively assess the efficacy of different HIPEC regimens in the early stage, and to lay the foundation for optimizing the HIPEC regimens and exploring new therapeutic targets.

Match to trials
Find the right clinical trials for you in under a minute
Get started
GaStrointestinal STIMULation As a Treatment of Postoperative IlEus Following Extensive Surgery (STIMULATE). -A Prospective Double-blinded Randomized Controlled Trial

Summary: The goal of this clinical trial is to investigate the effect of gastrointestinal stimulation with a pacemaker on the length of postoperative bowel paralysis in patients undergoing major abdominal surgery due to metastasizing colorectal cancer, appendiceal cancer or pseudomyxoma peritonei. The main question it aims to answer is if the length of postoperative ileus is reduced when the gastrointestin...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Pseudomyxoma Peritonei?